Literature DB >> 972854

Affinity chromatography of thymidine kinase from a rat colon adenocarcinoma.

E P Kowal, G Markus.   

Abstract

Thymidine kinase from a transplantable colon adenocarcinoma, induced by 1,2-dimethylhydrazine and maintained in CDF rats, was purified by affinity chromatography using thymidine-3'(4-aminophenylphosphate) coupled to carboxyhexyl-Sepharose. Most of the contaminating protein passed through the column; non-specifically adsorbed protein was washed from the column by 0.1 M KC1 in 0.01 M Tris-HC1, 7.5. Thymidine kinase was eluted with 0.1 mM thymidine, 0.1 M KC1 in 0.01 M Tris-HC1, pH 7.5. The purified enzyme accounted for about 26% of the applied activity; the specific activity of the purified material (peak fraction) was 3,500 moles TMP formed per mg protein per 10 min., a 1,800-fold purification of the applied extract. The preparation is free of nucleoside phosphotransferase, but contains other protein impurities. Purification was completed in less than 1 hour, making this a useful procedure for isolation of this unstable enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 972854     DOI: 10.1080/00327487608061625

Source DB:  PubMed          Journal:  Prep Biochem        ISSN: 0032-7484


  10 in total

1.  Unique metabolism of a novel antiviral L-nucleoside analog, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil: a substrate for both thymidine kinase and deoxycytidine kinase.

Authors:  S H Liu; K L Grove; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Mosquito has a single multisubstrate deoxyribonucleoside kinase characterized by unique substrate specificity.

Authors:  Wolfgang Knecht; Gitte Ebert Petersen; Michael Paolo Bastner Sandrini; Leif Søndergaard; Birgitte Munch-Petersen; Jure Piskur
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

3.  Inhibition of mouse LM cell replication by trifluorothymidine: role of cytosolic deoxythymidine kinase.

Authors:  B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

4.  Purification and biochemical characterization of deoxythymidine kinase of deoxythymidine kinase-deficient mouse 3T3 cells biochemically transformed by equine herpesvirus type 1.

Authors:  J J McGowan; G P Allen; G A Gentry
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Biochemical characterization of equine herpesvirus type 3-induced deoxythymidine kinase purified from lytically infected horse embryo dermal fibroblasts.

Authors:  J J McGowan; G P Allen; J M Barnett; G A Gentry
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

6.  Biochemical and immunological characterization of deoxythymidine kinase of thymidine kinaseless HeLa cells biochemically transformed by herpes simplex virus type.

Authors:  Y C Cheng; K C Chadha; R G Hughes
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

7.  Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.

Authors:  N Ono; S Iwayama; K Suzuki; T Sekiyama; H Nakazawa; T Tsuji; M Okunishi; T Daikoku; Y Nishiyama
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Trichomonas vaginalis thymidine kinase: purification, characterization and search for inhibitors.

Authors:  S Strosselli; S Spadari; R T Walker; I Basnak; F Focher
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

9.  Thymidine kinase mutants obtained by random sequence selection.

Authors:  K M Munir; D C French; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  3'-Amino thymidine affinity matrix for the purification of herpes simplex virus thymidine kinase.

Authors:  P P Tung; J Respass; W C Summers
Journal:  Yale J Biol Med       Date:  1996 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.